Sort
48,018 grants matching “immunotherapy”
Individualized in situ vaccination by radiation and immunotherapy
$376,098Sandra Demaria · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · CA
Dectin-1 signaling drives pancreatic oncogenesis by inducing macrophage-mediated adaptive immune suppression
$376,098George Miller · New York University School Of Medicine · R01 · FY2019 · CA
Mapping the Critical Epitopes of Ara h 2 and Ara h 6
$376,098Stephen C. Dreskin · University Of Colorado Denver · R01 · FY2013 · AI
Project-001
$376,080Margaret M Madeleine · Fred Hutchinson Cancer Research Center · U54 · FY2019 · CA
Reprogramming the Tumor Microenvironment in Pancreas Cancer to Enhance Immunotherapy
$376,075Nipun B. Merchant · University Of Miami School Of Medicine · R01 · FY2022 · CA
An Innovative Immune Therapy with Antibiotics to Treat Deadly Excess Inflammation in Sepsis and ARDS Induced from Severe Bacterial Infection in Geriatric Patients
$376,045Eugene Roussel · Bioprovar Corporation · U44 · FY2021 · AG
Project 2: Combined personal neoantigen-targeting cancer vaccines with immune checkpoint blockade for ovarian cancer
$376,043Panagiotis Konstantinopoulos · Dana-Farber Cancer Inst · P50 · FY2022 · CA
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$376,000Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2023 · NS
Arginine Metabolism Regulates Myeloid Immune Suppression in Glioblastoma
$376,000Maciej S Lesniak · Northwestern University At Chicago · R01 · FY2022 · NS
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$376,000Adam M Sonabend · Northwestern University At Chicago · R01 · FY2022 · NS
MAPK as target of glioma immunoediting by CD8 T-cells, and predictor of response to immunotherapy
$376,000Adam M Sonabend · Northwestern University At Chicago · R01 · FY2023 · NS
The Role of IFI35 in Innate Immunity and Influenza Pathogenesis
$376,000Adrianus Cm Boon · Washington University · R01 · FY2016 · AI
Evaluating the Relationship Between Age and HIV-1 Persistence
$375,973Judith S. Currier · University Of California Los Angeles · UM1 · FY2024 · AI
MyD88-independent resistance to Toxoplasma in the intestine
$375,944Eric Y Denkers · University Of New Mexico · R01 · FY2022 · AI
Simian Vaccine Evaluation Unit (SVEU) - Core Activities
$375,872Mark Lewis · Bioqual, Inc. · N01 · FY2022 · AI
DEVELOPMENT & EVALUATION OF PRACTICABLE APPROACHES FOR GENERATION OF CYTOTOXIC &
$375,823Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA
Long Noncoding RNA Advocates Immune Resistant Microenvironment
$375,816Chunru Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Therapeutic immune mechanisms of anti-CD11a in psoriasis
$375,750Rockefeller University · R01 · FY2001 · AI
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
$375,750James J Mule · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Therapeutic immune mechanisms of daclizumab in psoriasis
$375,750Rockefeller University · R01 · FY2004 · AI
Therapeutic immune mechanisms of daclizumab in psoriasis
$375,750Rockefeller University · R01 · FY2003 · AI
Therapeutic immune mechanisms of anti-CD11a in psoriasis
$375,750Rockefeller University · R01 · FY2004 · AI
PATHOGENESIS OF C NEOFORMANS PERSISTENCE
$375,750Yeshiva University · R01 · FY2003 · HL
Therapeutic immune mechanisms of anti-CD11a in psoriasis
$375,750Rockefeller University · R01 · FY2003 · AI
PATHOGENESIS OF C NEOFORMANS PERSISTENCE
$375,750Yeshiva University · R01 · FY2002 · HL